Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib

Amie S. Corbin, Paul La Rosée, Eric P. Stoffregen, Brian J. Druker, Michael W. Deininger

Research output: Contribution to journalArticlepeer-review

286 Scopus citations

Fingerprint

Dive into the research topics of 'Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinib'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds